A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer

Publisher： Bentham Science Publishers

ISSN： 2212-697X

Source： Clinical Cancer Drugs, Vol.2, Iss.2, 2015-10, pp. : 87-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

By Whitehead Robert   Benedetti Jacqueline   Abbruzzese James   Ardalan Bach   Goodwin J.   Balcerzak Stanley   Samlowski Wolfram   Lenz Heinz-Josef   Macdonald John  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

By Cattel L.   La Grotta G.   Infante L.   Passera R.   Arpicco S.   Brusa P.   Bumma C.  

Il Farmaco, Vol. 58, Iss. 12, 2003-12 ,pp. : 1333-1338

Elsevier

Access to resources Recommend Favorite

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

By Tsavaris Nicolas   Kosmas Christos   Skopelitis Helias   Gouveris Panagiotis   Kopteridis Petros   Loukeris Dioynissis   Sigala Frantzeska   Zorbala-Sypsa Alexandra   Felekouras Evangelos   Papalambros Efstathios  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 369-375

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy

By Patel Hitendra   Stoller Ronald   Auber Miklos   Potter Douglas   Cai Chao   Zamboni William   Kiefer Gauri   Matin Khalid   Schmotzer Amy   Ramanathan Ramesh  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite